Pipobroman

This classification denotes an antineoplastic alkylating agent with the molecular formula C10H16Br2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Q99RDT97R, chemically known as 1,4-bis(3-bromopropionyl)piperazine but more generally known as pipobroman, which bears US NIH Compound Identifier 4842. European Medicines Agency schedules Pipobroman in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09875MIG. The term PIPOBROMAN is an International Non-Proprietary Name. World Health Organization schedules pipobroman in its Anatomical Therapeutic Chemical (ATC) Classification. PIPOBROMAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule pipobroman under HS 29335995 and SITC 51576. As of Q4 2014, PIPOBROMAN remains US FDA's Preferred Term for this commodity. Pipobroman bears US NLM identifiers UMLS ID C0031965 and NCI Concept Code C750. SMILES: C1CN(CCN1C(=O)CCBR)C(=O)CCBR.